Craneware plc (LON:CRW)‘s stock had its “buy” rating reissued by research analysts at Peel Hunt in a research report issued on Thursday. They currently have a GBX 1,335 ($16.54) price objective on the stock. Peel Hunt’s price target suggests a potential upside of 15.28% from the company’s previous close.

Shares of Craneware plc (LON:CRW) opened at 1160.00 on Thursday. The company’s market capitalization is GBX 311.46 million. The firm’s 50-day moving average is GBX 1,253.11 and its 200-day moving average is GBX 1,001.17. Craneware plc has a 12-month low of GBX 730.00 and a 12-month high of GBX 1,340.00.

The company also recently disclosed a dividend, which will be paid on Thursday, December 8th. Stockholders of record on Thursday, November 10th will be given a GBX 9 ($0.11) dividend. This is a positive change from Craneware plc’s previous dividend of $7.50. This represents a dividend yield of 0.86%. The ex-dividend date of this dividend is Thursday, November 10th.

In other news, insider Neilson,Keith acquired 5,388 shares of the business’s stock in a transaction dated Monday, September 19th. The stock was bought at an average cost of GBX 1,200 ($14.86) per share, for a total transaction of £64,656 ($80,089.19).

About Craneware plc

Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention.

Receive News & Stock Ratings for Craneware plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware plc and related stocks with our FREE daily email newsletter.